Rwanda is among the countries interested in Lenacapavir, a newly approved, long-acting preventive injection, though its cost is seemingly out of reach for many developing countries.

Younger children living with HIV with low BMI for their age were more likely than older children to fail first-line ...

Gandhi cited a recent study from the CDC showing that more than 2.2 million individuals in the US need PrEP, but only 336K ...